The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections

Applied Microbiology and Biotechnology

Volumn 97, Issue 7, 2013, Pages 3085-3096

  Myhrman, Emma ^a   Håkansson, Joakim ^a   Lindgren, Kerstin ^a   Björn, Camilla ^a   Sjöstrand, Veronika ^a   Mahlapuu, Margit ^a  

^a Pergamum AB   (Sweden)

Author keywords

Antibiotic resistance; Antimicrobial peptide; MRSA; Staphylococcus aureus; Wound infection

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL PEPTIDE; MRSA; STAPHYLOCOCCUS AUREUS; WOUND INFECTIONS;

ANTIBIOTICS; BACTERIA; CELL CULTURE; CELL MEMBRANES; RATS;

POLYPEPTIDES;

POLYPEPTIDE ANTIBIOTIC AGENT; PXL 150; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM; DISEASE TREATMENT; HOMINID; INFECTIOUS DISEASE; MEDICINE; PATHOGEN; PEPTIDE; SKIN DISORDER; WOUNDING;

ACINETOBACTER BAUMANNII; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG POTENCY; DRUG PURITY; ELECTROSPRAY; ESCHERICHIA COLI; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN CELL CULTURE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; RAT; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CELL MEMBRANE; DISEASE MODELS, ANIMAL; ERYTHROCYTES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; RATS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; SWINE; WOUND INFECTION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA; RATTUS; STAPHYLOCOCCUS AUREUS; SUIDAE;

EID: 84876682308     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4439-8     Document Type: Article

References (29)

1. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP (2011) Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 52:99-114. doi: 10.1093/cid/ciq067
2. Datamonitor (2009) Stakeholder opinions: skin and soft tissue infections. The end of the reign of vancomycin. Product Code: DMHC2519, Datamonitor. www.datamonitor.com/store
3. Elass-Rochard E, Legrand D, Salmon V, Roseanu A, Trif M, Tobias PS, Mazurier J, Spik G (1998) Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 66:486-491
4. Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM (2003) Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:196-203
5. Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37-51. doi: 10.1038/nrd3591
6. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE (2000) Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother 44:2086-2092
7. Friedrich CL, Rozek A, Patrzykat A, Hancock RE (2001) Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 276:24015-24022. doi: 10.1074/jbc.M009691200
8. Hancock RE, Rozek A (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206:143-149
9. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557. doi: 10.1038/nbt1267
10. Haversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I (2000) Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 68:5816-5823
11. Hersh AL, Chambers HF, Maselli JH, Gonzales R (2008) National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168:1585-1591. doi: 10.1001/archinte.168.14.1585
12. Houang ET, Greenwood D (1977) Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria. J Clin Pathol 30:738-744
13. Kosowska-Shick K, Clark C, Credito K, McGhee P, Dewasse B, Bogdanovich T, Appelbaum PC (2006) Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother 50:765-769. doi: 10.1128/AAC.50.2.765-769.2006
14. Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, Otvos L Jr (2001) The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40:3016-3026
15. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472. doi: 10.1016/j.coph.2006.04.006
16. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR (2007) Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 57:7-13. doi: 10.1016/j.diagmicrobio. 2006.05.009
17. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984. doi: 10.1001/jama.290.22. 2976
18. Nakajima Y, Ishibashi J, Yukuhiro F, Asaoka A, Taylor D, Yamakawa M (2003) Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria. Biochim Biophys Acta 1624:125-130
19. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr (2008) Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 51:291-298. doi: 10.1016/j.annemergmed.2007.12.004
20. Powers JP, Hancock RE (2003) The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691. doi: 10.1016/j.peptides.2003. 08.023
21. Saymen DG, Nathan P, Holder IA, Hill EO, Macmillan BG (1972) Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol 23:509-514
22. Schmidtchen A, Pasupuleti M, Morgelin M, Davoudi M, Alenfall J, Chalupka A, Malmsten M (2009) Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J Biol Chem 284:17584-17594. doi: 10.1074/jbc.M109.011650
23. Silvestro L, Weiser JN, Axelsen PH (2000) Antibacterial and antimembrane activities of cecropin A in Escherichia coli. Antimicrob Agents Chemother 44:602-607
24. Toke O (2005) Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 80:717-735. doi: 10.1002/bip. 20286
25. Wu M, Hancock RE (1999) Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 274:29-35
26. Xiong YQ, Yeaman MR, Bayer AS (1999) In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 43:1111-1117
27. Yamakawa T, Mitsuyama J, Hayashi K (2002) In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 49:455-465
28. Yeung AT, Gellatly SL, Hancock RE (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 68:2161-2176. doi: 10.1007/s00018-011-0710-x
29. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395. doi: 10.1038/415389a